Perennial allergic rhinitis. Perennial allergic rhinitis
Conditions
Interventions
Intervention involving consumption of allergen condensed Extract including saline grass and combination of weeds bought from GREER company for immunotherapy, Intervention involving consumption of
Treatment - Drugs
Sponsors
Vice chancellor for research, Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to 55 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: The risk of perennial allergic rhinitis; Positive skin test to allergens in the air; Clinical signs associated with skin test Exclusion criteria: History of autoimmune disease; Patients with systemic corticosteroids or immunosuppressive drugs for reasons other than allergic disease on the immune system use to be effective; Pregnancy; Immunocompromised patients, patients who have uncontrolled allergic asthma; Patients with malnutrition; Patients who received beta-blocker drugs; Patients with a history of anaphylaxis; patients With coexisting cardiovascular disease; During treatment, patients who are experiencing systemic reactions; Patients with mental disorders
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical symptoms. Timepoint: Befor the trial. Method of measurement: questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| FOXP3. Timepoint: 3 month later. Method of measurement: Flowcytometry.;IFN-?. Timepoint: 3 month later. Method of measurement: Flowcytometry.;IL-4. Timepoint: 3 month later. Method of measurement: Flowcytometry. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAli Fouladvand
Mashad Universityof Medcal Sciences
Outcome results
None listed